Tackling Cancer: Breast Cancer’s Biggest Current & Upcoming Players – Roche Holding Ltd. (ADR) (RHHBY), AstraZeneca plc (ADR) (AZN), ImmunoGen, Inc. (IMGN)
As I noted two weeks ago, cancer statistics are both staggering and disappointing.
Posts Tagged ‘NYSE:GSK’
Will Johnson & Johnson (JNJ) Help You Retire Rich?
Now more than ever, a comfortable retirement depends on secure, stable investments. Unfortunately, the right stocks for retirement won't just fall into your lap.
This Week in Biotech: Gilead Sciences, Inc. (GILD), GlaxoSmithKline plc (ADR) (GSK)
With the SPDR S&P Biotech Index up 31% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
What You Need to Know About Sarepta Therapeutics Inc (SRPT)’s Q4 Update
Sarepta Therapeutics Inc (NASDAQ:SRPT) was on fire in 2012, landing at the top of the list of The Motley Fool's best health-care stocks of the year.
Are Antibiotics Dead Weight for Johnson & Johnson (JNJ)?
Johnson & Johnson (NYSE:JNJ) may offer well-known personal care products such as Listerine and Neutrogena, but it also boasts an impressive portfolio of market-leading therapeutic...
Will Eli Lilly & Co. (LLY) Help You Retire Rich? – GlaxoSmithKline plc (ADR) (GSK), Johnson & Johnson (JNJ)
Now more than ever, a comfortable retirement depends on secure, stable investments. Unfortunately, the right stocks for retirement won't just fall into your lap.
Analyst Roundtable: Any Surprises in Amarin Corporation plc (ADR) (AMRN)’s Fourth Quarter?
Motley Fool health care analyst Max Macaluso and Fool contributor Brian Orelli sat down to discuss Amarin Corporation plc (ADR) (NASDAQ:AMRN) , a biotech that recently launched...
Pfizer Inc. (PFE), GlaxoSmithKline plc (ADR) (GSK), AbbVie Inc (ABBV): Will This HIV Triumph Change History?
Last year will long be remembered for its remarkable advances in the diagnosis and prevention of HIV; OraSure Technologies gained FDA approval for the first-ever at-home, over...
Why Impax Laboratories Inc (IPXL) Shares Cratered
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis...
Can’t-Miss Health-Care Events This Week: GlaxoSmithKline plc (ADR)(GSK), Theravance Inc (THRX)
On Monday, Depomed Inc (NASDAQ:DEPO) is expected to go before the FDA panel with its menopausal hot-flash drug, Serada.
This FDA Approval Is Actually a Big Deal: Dendreon Corporation (DNDN)
As we've learned in recent years, getting an approval from the Food and Drug Administration is only half the battle.
Is Abbott Laboratories (ABT)’s Universal Microbe Detector a Big Deal?
I think I have uncovered the real reason why Abbott Laboratories (NYSE:ABT) decided to spin off its pharmaceutical division into AbbVie Inc (NYSE:ABBV).
What’s Next for Dynavax Technologies Corporation (DVAX)?
Dynavax Technologies Corporation (NASDAQ:DVAX) is down more than 30% in early trading today following a Food and Drug Administration rejection for its hepatitis B vaccine Heplisav...
Pfizer Inc. (PFE): A Global Biotechnology Company in its 164th Year
A SWOT analysis is a look at a company’s strengths, weaknesses, opportunities, and threats, and is a great way to gain a detailed and thorough perspective on a company and its...
A Buyout In Amarin Corporation plc (ADR) (AMRN) Is Imminent!
All throughout Wall Street we keep hearing about Amarin Corporation plc (ADR) (NASDAQ:AMRN) being bought out by some type of Big Pharma company in the future. It's all rumors...
5 Great Stocks Yielding 5% – Lockheed Martin Corporation (LMT), AT&T Inc. (T)
Investors who love to receive income from their investments may be understandably frustrated by the current market environment. The Federal Reserve’s monetary policy has short...
5 Dividend Companies Favored by Top Investors: Entergy Corporation (ETR), BP plc (ADR) (BP)
I've been examining dividend stocks for nearly a year now, selecting what I feel are the absolute best for my own dividend portfolio.
Microsoft Corporation (MSFT) Yammers About Yammer Numbers
Microsoft Corporation (NASDAQ:MSFT) actively pursued getting into the social media space, and last summer consummated a courtship with a $1.2 billion acquisition of Yammer.
Are These 3 Stocks Down for the Count?: Ruckus Wireless Inc (RKUS) and More
Horse meat and Wal-Mart Stores, Inc.
Gilead Sciences, Inc. (GILD): A Pharmaceutical Growth Story You Can’t Afford To Miss
Gilead Sciences, Inc. (NASDAQ:GILD) is the world’s largest maker of HIV drugs, but has taken on a number of new initiatives to enter other areas of treatment.
Will ISIS Pharmaceuticals, Inc. (ISIS) Right Pfizer Inc. (PFE)’s Wrong?
ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) started the year strong with a Food and Drug Administration approval for genetic high cholesterol drug Kynamro.
VIVUS, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA): Will There Ever Be an Obesity Drug Blockbuster?
Investors are anxiously waiting for the launch of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) and Eisai's obesity drug Belviq, which will match up with VIVUS, Inc.
Has Avanir Pharmaceuticals, Inc. (AVNR) Become the Perfect Stock?
One thing's for sure: You'll never discover truly great investments unless you actively look for them.
The Next Stock You Should Consider: GlaxoSmithKline plc (ADR) (GSK)
Some of the best-performing stocks over the past several decades boast long histories of paying dividends to shareholders. Moreover, if these stocks sell for an apparent discount...
Is Johnson & Johnson (JNL) a Future Blockbuster?
Johnson & Johnson (NYSE:JNJ) may offer well-known personal care products such as Listerine and Neutrogena, but it also boasts an impressive portfolio of market leading therapeutic...
The Most Trustworthy Drugs on the Market: Pfizer Inc. (PFE), Bayer AG (BAYN)
How much is trustworthiness actually worth? That somewhat strange thought entered my brain recently after reviewing the latest Harris Physician Pulse Survey.
Warren Buffett’s Long-Term Dividend Holds: Sanofi SA (ADR) (SNY) and More
Warren Buffett has made a name for himself by snatching up companies at deep discounts and holding until he’s captured as much value as possible.
Is Now the Time to Buy GlaxoSmithKline plc (GSK)?
So right now I am trawling through the FTSE 100 and giving my verdict on every member of the blue-chip index.
We Love You, Just Not Enough to Buy You (Yet): Regeneron Pharmaceuticals Inc (REGN), Sanofi SA (SNY)
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) said Monday that it got a notice from its partner Sanofi SA (NYSE:SNY) saying that the pharma intends to buy additional shares of the...
Wall Street Loves Dynavax Technologies Corporation (DVAX). Should You?
Despite all of Wall Street's conflict and contention, a fortunate few companies enjoy unanimous support among professional analysts.
The Best Dividend in Big Pharma: Sanofi SA (SNY), Pfizer Inc. (PFE), GlaxoSmithKline plc (GSK)
Big pharma's a good place to start if you're looking for dividend stocks.
Has GlaxoSmithKline plc (GSK) Become the Perfect Stock?
One thing's for sure: You'll never discover truly great investments unless you actively look for them.
Part 2: Three Dividend Stocks You Must Buy – GlaxoSmithKline plc (GSK), The Coca-Cola Company (KO)
Despite the uncertainties of Fiscal Cliff, dividend stocks have emerged as a rock solid investment.
Eli Lilly & Co. (LLY): If You’re Going to Fail, Fail Quickly
It's not particularly surprising given that the drug failed a phase 3 trial in December, but it's still disappointing for a company that could really use a positive result.
Why I’m a Long-Term Investor in GlaxoSmithKline plc (GSK)
LONDON -- Back in 2007, I made the first of several purchases that together built up a small stake in GlaxoSmithKline plc (LSE:GSK) (NYSE:GSK) .
Gilead Sciences, Inc. (GILD) Earnings Blaze a Star-Studded Future
The global HIV market supports a large and lucrative business environment.
3 Biotechs Burning Through Cash: Keryx Biopharmaceuticals (KERX), Peregrine Pharmaceuticals (PPHM) and More
Young, upstart pharmaceutical and biotech companies do one thing that almost no other industry does. They go years without generating any revenue.
